Published • loading... • Updated
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
- Harbour BioMed appointed Dr. Lloyd Klickstein as their Scientific Advisor for Immunology to support their work in novel antibody therapeutics.
- Dr. Klickstein has over twenty years of experience in biopharmaceutical innovation, translational research, and clinical medicine.
- He is a renowned rheumatologist and immunologist and is currently the CEO of Koslapp Therapeutics.
- Dr. Jingsong Wang, CEO of Harbour BioMed, praised Dr. Klickstein's clinical and translational science expertise upon his appointment.
Insights by Ground AI
37 Articles
37 Articles
Bennington Banner+36 Reposted by 36 other sources
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 28, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today announced…
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources37
Leaning Left5Leaning Right6Center15Last UpdatedBias Distribution58% Center
Bias Distribution
- 58% of the sources are Center
58% Center
L 19%
C 58%
R 23%
Factuality
To view factuality data please Upgrade to Premium
